Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Host Factor 1 Protein | 3 | 2013 | 5 | 0.790 |
Why?
|
| Escherichia coli Proteins | 4 | 2013 | 359 | 0.720 |
Why?
|
| Escherichia coli | 3 | 2012 | 1203 | 0.480 |
Why?
|
| Pyrrolidinones | 2 | 2019 | 61 | 0.310 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2019 | 87 | 0.310 |
Why?
|
| Organophosphonates | 2 | 2019 | 64 | 0.310 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 1879 | 0.310 |
Why?
|
| Models, Molecular | 8 | 2021 | 1732 | 0.240 |
Why?
|
| Nucleic Acids | 1 | 2021 | 43 | 0.200 |
Why?
|
| Xanthines | 1 | 2021 | 29 | 0.200 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 82 | 0.200 |
Why?
|
| Glycoside Hydrolases | 1 | 2021 | 37 | 0.190 |
Why?
|
| Crystallography, X-Ray | 4 | 2021 | 627 | 0.190 |
Why?
|
| Ricin | 2 | 1998 | 34 | 0.190 |
Why?
|
| RNA, Messenger | 2 | 2009 | 6150 | 0.180 |
Why?
|
| DNA Replication | 1 | 2024 | 744 | 0.180 |
Why?
|
| Endopeptidase Clp | 1 | 2019 | 14 | 0.180 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2019 | 21 | 0.170 |
Why?
|
| Glutaminase | 1 | 2019 | 47 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 169 | 0.170 |
Why?
|
| Asparaginase | 1 | 2019 | 184 | 0.170 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 119 | 0.160 |
Why?
|
| Mitochondria | 2 | 2019 | 1282 | 0.150 |
Why?
|
| RNA, Ribosomal | 1 | 1996 | 83 | 0.140 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type II | 1 | 2016 | 7 | 0.140 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 931 | 0.140 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 392 | 0.140 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 279 | 0.140 |
Why?
|
| Phosphopeptides | 1 | 2015 | 65 | 0.130 |
Why?
|
| Cyclic GMP | 1 | 2016 | 116 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 1 | 2015 | 67 | 0.130 |
Why?
|
| src Homology Domains | 1 | 2015 | 124 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 4053 | 0.120 |
Why?
|
| Plakophilins | 1 | 2014 | 15 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3821 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2021 | 1230 | 0.120 |
Why?
|
| Tryptophan | 1 | 2013 | 127 | 0.120 |
Why?
|
| Binding Sites | 3 | 2019 | 2171 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2019 | 1258 | 0.100 |
Why?
|
| Protein Binding | 3 | 2019 | 3438 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 202 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 984 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2014 | 1620 | 0.090 |
Why?
|
| Polyadenylation | 1 | 2009 | 70 | 0.090 |
Why?
|
| RNA Stability | 1 | 2009 | 125 | 0.090 |
Why?
|
| RNA | 1 | 2013 | 1013 | 0.080 |
Why?
|
| HMGN2 Protein | 1 | 2007 | 1 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2019 | 1489 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2014 | 5270 | 0.080 |
Why?
|
| snRNP Core Proteins | 1 | 2007 | 9 | 0.080 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2007 | 43 | 0.080 |
Why?
|
| RNA, Bacterial | 1 | 2007 | 80 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2016 | 549 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2007 | 91 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2019 | 515 | 0.070 |
Why?
|
| Autoantigens | 1 | 2007 | 234 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 2796 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2007 | 397 | 0.070 |
Why?
|
| Ligands | 1 | 2007 | 995 | 0.060 |
Why?
|
| MRE11 Homologue Protein | 1 | 2024 | 39 | 0.060 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2024 | 52 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 576 | 0.060 |
Why?
|
| beta Catenin | 1 | 2007 | 688 | 0.060 |
Why?
|
| Rad51 Recombinase | 1 | 2024 | 126 | 0.060 |
Why?
|
| Pentosyltransferases | 1 | 2003 | 25 | 0.060 |
Why?
|
| RNA, Transfer | 1 | 2003 | 77 | 0.050 |
Why?
|
| DNA | 3 | 2024 | 2693 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 1143 | 0.050 |
Why?
|
| Animals | 9 | 2024 | 59536 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 144 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2014 | 189 | 0.050 |
Why?
|
| Mammary Glands, Animal | 2 | 2006 | 533 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2024 | 519 | 0.050 |
Why?
|
| Kinetics | 3 | 2003 | 2049 | 0.050 |
Why?
|
| Ecdysterone | 1 | 2000 | 6 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 4821 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2021 | 303 | 0.040 |
Why?
|
| Mice | 6 | 2024 | 34495 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2024 | 677 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 314 | 0.040 |
Why?
|
| Asparagine | 1 | 2019 | 38 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 164 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 171 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 6915 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2016 | 1487 | 0.040 |
Why?
|
| RNA, Plant | 1 | 1998 | 23 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2019 | 139 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 348 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 324 | 0.040 |
Why?
|
| Humans | 12 | 2024 | 261506 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 4938 | 0.040 |
Why?
|
| Neoplasms | 1 | 2024 | 15193 | 0.040 |
Why?
|
| Glutamine | 1 | 2019 | 299 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 566 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 370 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 905 | 0.040 |
Why?
|
| Point Mutation | 1 | 2019 | 769 | 0.030 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 2015 | 26 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2015 | 4804 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2019 | 1764 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 377 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 135 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2015 | 284 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 1869 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 358 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 4233 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 243 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 5710 | 0.030 |
Why?
|
| Cell Line | 2 | 2015 | 5114 | 0.030 |
Why?
|
| Prodrugs | 1 | 2015 | 217 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 498 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 14551 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2013 | 52 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 93 | 0.030 |
Why?
|
| DNA Repair | 1 | 2021 | 1872 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 999 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 195 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2014 | 270 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2014 | 234 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 3045 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 591 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 886 | 0.030 |
Why?
|
| Pyridines | 1 | 2019 | 1244 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 1037 | 0.030 |
Why?
|
| DNA Primers | 1 | 2014 | 1399 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1070 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 1062 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 388 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 571 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 1643 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 585 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 548 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 205 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 871 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 311 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 6086 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 706 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3552 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 3518 | 0.020 |
Why?
|
| Hexokinase | 1 | 2006 | 36 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2006 | 76 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 4143 | 0.020 |
Why?
|
| Multigene Family | 1 | 2006 | 425 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 6942 | 0.020 |
Why?
|
| Glycolysis | 1 | 2006 | 519 | 0.010 |
Why?
|
| Isomerases | 1 | 2003 | 19 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 1408 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2006 | 494 | 0.010 |
Why?
|
| Catalysis | 1 | 2003 | 250 | 0.010 |
Why?
|
| Magnesium | 1 | 2003 | 160 | 0.010 |
Why?
|
| Chromatin | 1 | 2007 | 942 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 359 | 0.010 |
Why?
|
| Ecdysteroids | 1 | 2000 | 3 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2000 | 85 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 2216 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 2508 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2007 | 1664 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 4917 | 0.010 |
Why?
|
| Formycins | 1 | 1998 | 1 | 0.010 |
Why?
|
| Ribitol | 1 | 1998 | 1 | 0.010 |
Why?
|
| Oligoribonucleotides | 1 | 1998 | 10 | 0.010 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 1998 | 11 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 365 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2000 | 286 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1998 | 47 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1998 | 101 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 356 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1694 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 3254 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 14289 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5159 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 15179 | 0.010 |
Why?
|
| Female | 2 | 2019 | 141928 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 11965 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 7548 | 0.010 |
Why?
|